Bioptik Technology Incorporation (TPEX:4161)
26.55
-0.15 (-0.56%)
Jan 22, 2026, 1:30 PM CST
TPEX:4161 Revenue
Bioptik Technology Incorporation had revenue of 215.16M TWD in the quarter ending September 30, 2025, with 2.39% growth. This brings the company's revenue in the last twelve months to 829.18M, down -6.21% year-over-year. In the year 2024, Bioptik Technology Incorporation had annual revenue of 865.34M with 4.45% growth.
Revenue (ttm)
829.18M
Revenue Growth
-6.21%
P/S Ratio
1.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 865.34M | 36.83M | 4.45% |
| Dec 31, 2023 | 828.50M | 60.75M | 7.91% |
| Dec 31, 2022 | 767.75M | 29.86M | 4.05% |
| Dec 31, 2021 | 737.89M | 252.29M | 51.96% |
| Dec 31, 2020 | 485.60M | -80.82M | -14.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.82B |
| Cowealth Medical Holding | 3.41B |
| Wellell | 2.39B |
| OK Biotech | 1.64B |
| Dynamic Medical Technologies | 1.43B |
| AViTA | 896.85M |
| Diamond Biotechnology | 698.11M |
| Applied BioCode | 443.69M |